OKAPI:Orbits | $14,830,855 | (Apr 29, 2025)
Overture Life | $20,600,000 | (Apr 29, 2025)
Symbiotic(US) | $29,000,000 | (Apr 29, 2025)
Certified by Founder
Lodge
Clade Therapeutics
start up
United States
- Cambridge, MA
- 03/11/2021
- Series A
- $87,000,000
Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located in the heart of Cambridge was recently launched by an exceptional group of academic leaders and successful bioentrepreneurs converging stem cell biology, immunology, regenerative medicine, and gene editing into the next-generation of stem cell-derived medicines.
- Industry Biotechnology Research
- Website https://cladetx.com/
- LinkedIn https://www.linkedin.com/company/clade-therapeutics/
Related People
Jim GlasheenCo Founder
United States -
Boston, Massachusetts,
Experienced life sciences executive with a demonstrated history of working in academia, venture capital and consulting. Skilled in biotech, pharmaceuticals, business strategy, Business Development, M&A / licensing, start-up ventures, and entrepreneurship.
Lightrun | $70,000,000 | (Apr 29, 2025)
NetFoundry | $12,000,000 | (Apr 29, 2025)
node.energy | $17,088,369 | (Apr 29, 2025)
Cipher Surgical | $10,000,000 | (Apr 29, 2025)
Ovo Labs | $5,372,520 | (Apr 29, 2025)
P-1 AI | $23,000,000 | (Apr 29, 2025)
Deferred | $3,600,000 | (Apr 29, 2025)
Fora Travel | $40,000,000 | (Apr 29, 2025)
Poppins | $5,697,525 | (Apr 29, 2025)